127 related articles for article (PubMed ID: 38183983)
1. Cleavage of the pseudoprotease iRhom2 by the signal peptidase complex reveals an ER-to-nucleus signaling pathway.
Dulloo I; Tellier M; Levet C; Chikh A; Zhang B; Blaydon DC; Webb CM; Kelsell DP; Freeman M
Mol Cell; 2024 Jan; 84(2):277-292.e9. PubMed ID: 38183983
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.
Rabinowitsch AI; Maretzky T; Weskamp G; Haxaire C; Tueshaus J; Lichtenthaler SF; Monette S; Blobel CP
J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37282854
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
4. Pathological mutations reveal the key role of the cytosolic iRhom2 N-terminus for phosphorylation-independent 14-3-3 interaction and ADAM17 binding, stability, and activity.
Bläsius K; Ludwig L; Knapp S; Flaßhove C; Sonnabend F; Keller D; Tacken N; Gao X; Kahveci-Türköz S; Grannemann C; Babendreyer A; Adrain C; Huth S; Baron JM; Ludwig A; Düsterhöft S
Cell Mol Life Sci; 2024 Feb; 81(1):102. PubMed ID: 38409522
[TBL] [Abstract][Full Text] [Related]
5. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
[TBL] [Abstract][Full Text] [Related]
6. Rhomboid family member 2 regulates cytoskeletal stress-associated Keratin 16.
Maruthappu T; Chikh A; Fell B; Delaney PJ; Brooke MA; Levet C; Moncada-Pazos A; Ishida-Yamamoto A; Blaydon D; Waseem A; Leigh IM; Freeman M; Kelsell DP
Nat Commun; 2017 Jan; 8():14174. PubMed ID: 28128203
[TBL] [Abstract][Full Text] [Related]
7. Inactive rhomboid proteins RHBDF1 and RHBDF2 (iRhoms): a decade of research in murine models.
Burzenski LM; Low BE; Kohar V; Shultz LD; Wiles MV; Hosur V
Mamm Genome; 2021 Dec; 32(6):415-426. PubMed ID: 34477920
[TBL] [Abstract][Full Text] [Related]
8. p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.
Arcidiacono P; Webb CM; Brooke MA; Zhou H; Delaney PJ; Ng KE; Blaydon DC; Tinker A; Kelsell DP; Chikh A
Nat Commun; 2018 Mar; 9(1):1021. PubMed ID: 29523849
[TBL] [Abstract][Full Text] [Related]
9. iRHOM2: A Regulator of Palmoplantar Biology, Inflammation, and Viral Susceptibility.
Chao-Chu J; Murtough S; Zaman N; Pennington DJ; Blaydon DC; Kelsell DP
J Invest Dermatol; 2021 Apr; 141(4):722-726. PubMed ID: 33080304
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of rhomboid-like pseudoproteases in inflammatory and innate immune responses.
Luo WW; Shu HB
FEBS Lett; 2017 Oct; 591(20):3182-3189. PubMed ID: 28815577
[TBL] [Abstract][Full Text] [Related]
11. Rhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin.
Hosur V; Johnson KR; Burzenski LM; Stearns TM; Maser RS; Shultz LD
Proc Natl Acad Sci U S A; 2014 May; 111(21):E2200-9. PubMed ID: 24825892
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.
Grieve AG; Xu H; Künzel U; Bambrough P; Sieber B; Freeman M
Elife; 2017 Apr; 6():. PubMed ID: 28432785
[TBL] [Abstract][Full Text] [Related]
13. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
Al-Salihi MA; Lang PA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
[TBL] [Abstract][Full Text] [Related]
14. Rhomboid proteins: a role in keratinocyte proliferation and cancer.
Etheridge SL; Brooke MA; Kelsell DP; Blaydon DC
Cell Tissue Res; 2013 Feb; 351(2):301-7. PubMed ID: 23263464
[TBL] [Abstract][Full Text] [Related]
15. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17.
Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585
[TBL] [Abstract][Full Text] [Related]
16. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
Elife; 2018 Jun; 7():. PubMed ID: 29897336
[TBL] [Abstract][Full Text] [Related]
17. iRhoms; Its Functions and Essential Roles.
Lee MY; Nam KH; Choi KC
Biomol Ther (Seoul); 2016 Mar; 24(2):109-14. PubMed ID: 26869525
[TBL] [Abstract][Full Text] [Related]
18. Status update on iRhom and ADAM17: It's still complicated.
Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of rhomboid family proteins in mammalian biology and disease.
Bergbold N; Lemberg MK
Biochim Biophys Acta; 2013 Dec; 1828(12):2840-8. PubMed ID: 23562403
[TBL] [Abstract][Full Text] [Related]
20. iRhom2 inhibits bile duct obstruction-induced liver fibrosis.
Sundaram B; Behnke K; Belancic A; Al-Salihi MA; Thabet Y; Polz R; Pellegrino R; Zhuang Y; Shinde PV; Xu HC; Vasilevska J; Longerich T; Herebian D; Mayatepek E; Bock HH; May P; Kordes C; Aghaeepour N; Mak TW; Keitel V; Häussinger D; Scheller J; Pandyra AA; Lang KS; Lang PA
Sci Signal; 2019 Oct; 12(605):. PubMed ID: 31662486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
